Differences in Prediagnostic Serum Metabolomic and Lipidomic Profiles Between Cirrhosis Patients with and without Incident Hepatocellular Carcinoma
Using prediagnostic serum samples, we identified a promising metabolites panel that accurately identifies patients with cirrhosis who progressed to HCC. Further validation of this panel is required.
Authors
- Hannah Powell (ORCID: https://orcid.org/0000-0002-6604-4773)
- Michael E. Scheurer (ORCID: https://orcid.org/0000-0002-8379-6088)
- Emad Mohamed Salem (ORCID: https://orcid.org/0009-0008-5160-7431)
- Hashem B. El‐Serag (ORCID: https://orcid.org/0000-0001-5964-7579)
- Aaron P. Thrift (ORCID: https://orcid.org/0000-0002-0084-5308)
- Luis Olivares
- Omar Najjar (ORCID: https://orcid.org/0009-0001-3210-2023)
- Christie Mitchell Ballantyne (ORCID: https://orcid.org/0000-0002-6432-1730)
- Cristian Coarfa (ORCID: https://orcid.org/0000-0002-4183-4939)
- Sandra L. Grimm (ORCID: https://orcid.org/0000-0002-0682-3134)
- Bing Yu (ORCID: https://orcid.org/0000-0003-4818-1077)
- Salma Kaochar (ORCID: https://orcid.org/0000-0001-9437-8829)
- Elisa Ruiz-Echartea
- Abeer Alsarraj
Institutions
- Baylor College of Medicine (US)
- The University of Texas Health Science Center at Houston (US)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2024-09-01
- DOI
- https://doi.org/10.2147/jhc.s474010
- Citations
- 3
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.16
Funders
- Cancer Prevention and Research Institute of Texas
- National Institutes of Health
- National Cancer Institute
- National Institute of General Medical Sciences
- National Institute of Diabetes and Digestive and Kidney Diseases
- National Institute of Environmental Health Sciences